Dermatology News

Enanthemas were commonly reported among patients with non-classic forms of pityriasis rosea, including persistent and pediatric forms of the disease.

Recent 12-month data from a phase 2b trial demonstrated that Genocea Biosciences’ lead GEN-003 vaccine regimen reduced the median rate of genital lesions by nearly 50% compared with placebo among patients with herpes simplex virus-2.

The last few years have seen a growing force of infectious disease challenges that together pose an unprecedented range of threats to health here in the United States and in countries around the world where Americans travel and conduct business. While outbreaks of Ebola, Zika, SARS and MERS have spread from their places of origin with devastating impacts, rising rates of resistance to antimicrobial drugs threaten the gains of modern medicine at home and globally. New and re-emerging diseases with pandemic potential continue to surface, and diseases that include tuberculosis, once considered all but conquered, have evolved faster than the medicines to control them, to pose new dangers.

The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute bacterial skin and skin structure infections, or ABSSSIs, including MRSA.

In November 2015, researchers from China reported the emergence of a gene conferring resistance to colistin, named mcr-1. This report was followed, less than a year later, by the first incidence of an mcr-1–positive infection — Escherichia coli — in a U.S. patient.

Paratek Pharmaceuticals recently announced that its investigational antibiotic omadacycline — a once-daily, oral treatment for acute bacterial skin and skin structure infections, or ABSSSIs — met all primary and secondary endpoints specified by the FDA and European Medicines Agency in a recent phase 3 study that compared the safety and efficacy of the drug with twice-daily Zyvox.

The Trump administration has named Georgia health commissioner Brenda Fitzgerald, MD, to be the next CDC director.

Bariatric surgery was associated with a significant increase in the risk for intra-abdominal infections and urinary tract infections in a study published in Clinical Infectious Diseases.

Another study has shown the clinical benefit of adding antibiotic therapy to incision and drainage treatment for uncomplicated skin abscesses.

The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute bacterial skin and skin structure infections, or ABSSSIs, including MRSA.